02 Jun 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 May 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
19 May 23	List of Directors and their Role and Function
19 May 23	POLL RESULTS OF ANNUAL GENERAL MEETING 2023 AND RETIREMENT OF DIRECTOR
17 May 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
12 May 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
11 May 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
08 May 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
28 Apr 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
25 Apr 23	UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2023
20 Apr 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
18 Apr 23	Notice of Annual General Meeting
14 Apr 23	PRE-LISTING TUTORING APPLICATION IN RELATION TO PROPOSED LISTING OF JIANGSU BEST NEW MEDICAL ON THE BEIJING STOCK EXCHANGE
13 Apr 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
11 Apr 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 Mar 23	VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALISED MEDICINES PROCUREMENT
28 Mar 23	Final Dividend for the year ended 31 December 2022
28 Mar 23	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022
27 Mar 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
24 Mar 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
24 Mar 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Mar 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
22 Mar 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Mar 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
16 Mar 23	DATE OF BOARD MEETING
06 Mar 23	POSITIVE PROFIT ALERT
20 Feb 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
06 Feb 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
02 Feb 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 Jan 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
19 Jan 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT AND BUSINESS DEVELOPMENT
13 Jan 23	POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 13 JANUARY 2023
09 Jan 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
05 Jan 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT AND BUSINESS DEVELOPMENT
04 Jan 23	VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT

28 Dec 22	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
28 Dec 22	APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN THE COMPOSITION OF BOARD COMMITTEES
28 Dec 22	Remuneration Committee Terms of Reference
20 Dec 22	NOTICE OF EXTRAORDINARY GENERAL MEETING
18 Dec 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
13 Dec 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
28 Nov 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
14 Nov 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
28 Oct 22	(1) PROPOSED ADOPTION OF NEW SHARE OPTION SCHEME AND (2) SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DISCLOSURES RELATING TO THE 2012 SHARE OPTION SCHEME
19 Oct 22	UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2022
10 Oct 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
26 Sep 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
13 Sep 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
07 Sep 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
05 Sep 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
29 Aug 22	Interim Dividend for the six months ended 30 June 2022
29 Aug 22	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022
17 Aug 22	DATE OF BOARD MEETING
01 Aug 22	POSITIVE PROFIT ALERT
13 Jul 22	VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT
06 Jul 22	QUOTATION OF JIANGSU BEST NEW MEDICAL ON THE NEEQ
04 Jul 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Jun 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
21 Jun 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
14 Jun 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
27 May 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
24 May 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 May 22	AMENDED AND RESTATED ARTICLES OF ASSOCIATION
23 May 22	POLL RESULTS OF ANNUAL GENERAL MEETING 2022
16 May 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
13 May 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
28 Apr 22	APPROVAL OF QUOTATION OF JIANGSU BEST NEW MEDICAL ON THE NEEQ
19 Apr 22	Notice of Annual General Meeting
19 Apr 22	UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2022
06 Apr 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
29 Mar 22	PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION
29 Mar 22	Final Dividend for the year ended 31 December 2021
29 Mar 22	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
18 Mar 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
18 Mar 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Mar 22	DATE OF BOARD MEETING
09 Mar 22	DISCLOSEABLE TRANSACTION - ACQUISITION OF TARGET COMPANY
07 Mar 22	BUSINESS UPDATE - LETTER OF INTENT
09 Feb 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
28 Jan 22	POSSIBLE SPIN-OFF AND SEPARATE QUOTATION OF JIANGSU BEST NEW MEDICAL ON THE NEEQ
11 Jan 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
10 Jan 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
06 Jan 22	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT

28 Dec 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
14 Dec 21	VOLUNTARY ANNOUNCEMENT - HYDROXYETHYL STARCH 130 AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
13 Dec 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON POSSIBLE SPIN-OFF OF JIANGSU BEST NEW MEDICAL
20 Oct 21	UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2021
18 Oct 21	VOLUNTARY ANNOUNCEMENT - POSSIBLE SPIN-OFF AND QUOTATION AND/OR LISTING ON A STOCK EXCHANGE IN MAINLAND CHINA
11 Oct 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Sep 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
10 Sep 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
03 Sep 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
27 Aug 21	List of Directors and their Role and Function
27 Aug 21	APPOINTMENT AND RESIGNATION OF EXECUTIVE DIRECTORS
27 Aug 21	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021
25 Aug 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Aug 21	DATE OF BOARD MEETING
29 Jul 21	DISCLOSEABLE TRANSACTION - ACQUISITION OF LISTED SECURITIES
28 Jul 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Jul 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
06 Jul 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
02 Jul 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 Jun 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
24 Jun 21	VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT
27 May 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
21 May 21	POLL RESULTS OF EXTRAORDINARY GENERAL MEETING
21 May 21	POLL RESULTS OF ANNUAL GENERAL MEETING 2021
03 May 21	NOTICE OF EXTRAORDINARY GENERAL MEETING
30 Apr 21	UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2021
19 Apr 21	Notice of Annual General Meeting
14 Apr 21	CONTINUING CONNECTED TRANSACTIONS - MASTER SALE AND PURCHASE AGREEMENT
12 Apr 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 Mar 21	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020
25 Mar 21	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
18 Mar 21	DATE OF BOARD MEETING
12 Mar 21	VOLUNTARY ANNOUNCEMENT - METRONIDAZOLE AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
01 Mar 21	CHANGE OF ADDRESS OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS
26 Feb 21	PROFIT WARNING
03 Feb 21	VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT
21 Jan 21	VOLUNTARY ANNOUNCEMENT - FLUCONAZOLE AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
13 Jan 21	VOLUNTARY ANNOUNCEMENT - CIPROFLOXACIN LACTATE AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
12 Jan 21	GRANT OF SHARE OPTIONS

30 Dec 20	VOLUNTARY ANNOUNCEMENT - AMBROXOL HYDROCHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
02 Dec 20	VOLUNTARY ANNOUNCEMENT - MOXIFLOXACIN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
10 Nov 20	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
05 Nov 20	VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
30 Oct 20	UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2020
14 Oct 20	CHANGE OF NAME OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS
25 Aug 20	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2020
21 Aug 20	VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT
19 Aug 20	VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT AND PRODUCT DEVELOPMENT
13 Aug 20	DATE OF BOARD MEETING
07 Aug 20	PROFIT WARNING
29 Jul 20	VOLUNTARY ANNOUNCEMENT - INTRA-GROUP RESTRUCTURING FOR POSSIBLE SPIN-OFF AND SEPARATE LISTING
22 Jul 20	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
20 Jul 20	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
22 May 20	POLL RESULTS OF ANNUAL GENERAL MEETING 2020
24 Apr 20	CONTINUING CONNECTED TRANSACTION - REVISION OF ANNUAL CAP
20 Apr 20	Notice of Annual General Meeting
20 Apr 20	UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2020
30 Mar 20	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019
23 Mar 20	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
18 Mar 20	DATE OF BOARD MEETING
24 Feb 20	VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
20 Feb 20	VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
19 Feb 20	INSIDE INFORMATION - Inclusion of Abidol in Diagnosis and Treatment Program for Novel Coronavirus Infected Pneumonia (Trial Version 6)
06 Feb 20	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
05 Feb 20	INSIDE INFORMATION, UNUSUAL TRADING VOLUME AND PRICE MOVEMENTS, RESUMPTION OF TRADING
05 Feb 20	Trading Halt
29 Jan 20	VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
15 Jan 20	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT

02 Dec 19	INSIDE INFORMATION - LAND REPURCHASE AGREEMENT
21 Oct 19	UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019
30 Sep 19	CONTINUING CONNECTED TRANSACTION - REVISION OF ANNUAL CAP
17 Sep 19	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
26 Aug 19	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2019
14 Aug 19	DATE OF BOARD MEETING
10 Jun 19	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 May 19	VOLUNTARY ANNOUNCEMENT - FLUCONAZOLE TABLETS PASS CONSISTENCY EVALUATION
08 May 19	POLL RESULTS OF ANNUAL GENERAL MEETING 2019
17 Apr 19	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Apr 19	UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2019
28 Mar 19	Notice of Annual General Meeting
13 Mar 19	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
05 Mar 19	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
01 Mar 19	DATE OF BOARD MEETING
18 Feb 19	POSITIVE PROFIT ALERT
07 Jan 19	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT

28 Dec 18	ADOPTION OF RESTRICTED SHARE AWARD SCHEME
31 Oct 18	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
18 Oct 18	UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2018
27 Aug 18	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2018
15 Aug 18	DATE OF BOARD MEETING
06 Aug 18	POSITIVE PROFIT ALERT
13 Jul 18	VOLUNTARY ANNOUNCEMENT RECOGNITION AS THE NATIONAL ENTERPRISE TECHNOLOGY CENTRE
20 Jun 18	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
04 Jun 18	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 May 18	VOLUNTARY ANNOUNCEMENT - RECEIVED THE SCIENCE AND TECHNOLOGY PROGRESS AWARD
16 May 18	POLL RESULTS OF ANNUAL GENERAL MEETING 2018
25 Apr 18	CONTINUING CONNECTED TRANSACTION - MASTER SALE AND PURCHASE AGREEMENT
24 Apr 18	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
16 Apr 18	UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2018
12 Apr 18	Notice of Annual General Meeting
27 Mar 18	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2017
22 Mar 18	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
15 Mar 18	DATE OF BOARD MEETING
05 Mar 18	VOLUNTARY ANNOUNCEMENT - UPDATES ON TECHNOLOGY AND PRODUCT DEVELOPMENT
28 Feb 18	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
27 Feb 18	POSITIVE PROFIT ALERT

11 Dec 17	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
24 Nov 17	List of Directors and their Role and Function
24 Nov 17	APPOINTMENT OF NON-EXECUTIVE DIRECTOR
18 Oct 17	VOLUNTARY ANNOUNCEMENT - COOPERATION AGREEMENT
10 Oct 17	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2017
30 Aug 17	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Aug 17	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2017
11 Aug 17	DATE OF BOARD MEETING
01 Aug 17	POSITIVE PROFIT ALERT
21 Jul 17	CONTINUING CONNECTED TRANSACTION - MASTER SALE AND PURCHASE AGREEMENT
24 May 17	POLL RESULTS OF ANNUAL GENERAL MEETING 2017
18 May 17	CHANGE OF NAME AND ADDRESS OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS
18 Apr 17	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2017
12 Apr 17	Notice of Annual General Meeting
29 Mar 17	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2016
17 Mar 17	DATE OF BOARD MEETING

29 Dec 16	VOLUNTARY ANNOUNCEMENT - APPROVAL FOR ESTABLISHMENT OF NATIONAL AND LOCAL JOINT ENGINEERING LABORATORY
21 Nov 16	TEMPORARY SUSPENSION OF PRODUCTION AND RESUMPTION OF TRADING
21 Nov 16	TRADING HALT
27 Oct 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Oct 16	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2016
17 Oct 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
31 Aug 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 Aug 16	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2016
18 Aug 16	DATE OF BOARD MEETING
14 Jul 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
01 Jun 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
27 May 16	POLL RESULTS OF ANNUAL GENERAL MEETING 2016
29 Apr 16	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2016
25 Apr 16	Notice of Annual General Meeting
22 Apr 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
21 Apr 16	PROPOSED CHANGE OF AUDITOR
15 Apr 16	PROPOSED GRANT OF SHARE OPTIONS
11 Apr 16	UPDATE ON DISCLOSEABLE TRANSACTION - ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL IN JIANGSU BOSHENG YI YONG XIN CAI LIAO CO., LTD. - COMPLETION OF FURTHER SUPPLEMENTAL AGREEMENT FOR ISSUE OF CONSIDERATION SHARES
31 Mar 16	UPDATE ON DISCLOSEABLE TRANSACTION - ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL IN JIANGSU BOSHENG YI YONG XIN CAI LIAO CO., LTD. - FURTHER SUPPLEMENTAL AGREEMENT FOR ISSUE OF CONSIDERATION SHARES
30 Mar 16	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2015
23 Mar 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
16 Mar 16	DATE OF BOARD MEETING
15 Mar 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
07 Mar 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
24 Feb 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
02 Feb 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
01 Feb 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
20 Jan 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
06 Jan 16	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT

29 Dec 15	UPDATE ON DISCLOSEABLE TRANSACTION - ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL IN JIANGSU BOSHENG YI YONG XIN CAI LIAO CO., LTD.
18 Dec 15	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Nov 15	VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
26 Oct 15	VOLUNTARY ANNOUNCEMENT - APPROVAL FOR ESTABLISHMENT OF POST-DOCTORAL SCIENTIFIC RESEARCH WORKSTATION
19 Oct 15	GRANT OF SHARE OPTIONS
16 Oct 15	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2015
01 Sep 15	DISCLOSEABLE TRANSACTION - ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL IN JIANGSU BOSHENG YI YONG XIN CAI LIAO CO., LTD.
31 Aug 15	CLOSING, AND RESULTS, OF THE CASH OFFER BY BNP PARIBAS SECURITIES (ASIA) LIMITED ON BEHALF OF SSY GROUP LIMITED TO BUY-BACK UP TO 150,000,000 SHARES FOR HK$3.30 IN CASH PER SHARE
31 Aug 15	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2015
20 Aug 15	DATE OF BOARD MEETING
19 Aug 15	UNCONDITIONAL CASH OFFER BY BNP PARIBAS SECURITIES (ASIA) LIMITED ON BEHALF OF SSY GROUP LIMITED TO BUY-BACK UP TO 150,000,000 SHARES FOR HK$3.30 IN CASH PER SHARE
17 Aug 15	POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING AND FULFILLMENT OF CONDITIONS OF THE OFFER
31 Jul 15	DESPATCH OF OFFER DOCUMENT AND EXPECTED TIMETABLE OF THE OFFER
31 Jul 15	NOTICE OF THE EXTRAORDINARY GENERAL MEETING
24 Jul 15	CLARIFICATION ANNOUNCEMENT ON THE DELAY IN DESPATCH OF OFFER DOCUMENT
23 Jul 15	DELAY IN DESPATCH OF OFFER DOCUMENT
02 Jul 15	CONDITIONAL CASH OFFER BY BNPP SECURITIES ON BEHALF OF SSY GROUP LIMITED TO BUY-BACK UP TO 150,000,000 SHARES FOR HK$3.30 IN CASH PER SHARE AND APPLICATION FOR WHITEWASH WAIVER AND RESUMPTION OF TRADING
24 Jun 15	TRADING HALT
15 Jun 15	BUSINESS UPDATE
09 Jun 15	CHANGE OF COMPANY NAME, STOCK SHORT NAME AND COMPANY WEBSITE
15 May 15	POLL RESULTS OF ANNUAL GENERAL MEETING 2015
30 Apr 15	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2015
15 Apr 15	NOTICE OF ANNUAL GENERAL MEETING
01 Apr 15	CHANGE OF CHIEF FINANCIAL OFFICER, COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
27 Mar 15	PROPOSED CHANGE OF COMPANY NAME
27 Mar 15	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2014
11 Mar 15	DATE OF BOARD MEETING
09 Feb 15	POSITIVE PROFIT ALERT
04 Feb 15	FORMATION OF JOINT VENTURE COMPANY
22 Jan 15	BUSINESS UPDATE

15 Dec 14	List of Directors and their Role and Function
15 Dec 14	RESIGNATION OF EXECUTIVE DIRECTOR AND APPOINTMENT OF EXECUTIVE DIRECTOR
03 Nov 14	ANNOUNCEMENT PURSUANT TO RULE 13.09(2)(a) OF THE LISTING RULES COMPLETION OF THE DISPOSAL AGREEMENT
30 Oct 14	CLARIFICATION ANNOUNCEMENT PURSUANT TO RULE 13.09(2)(a) OF THE LISTING RULES
30 Oct 14	TRADING HALT
29 Oct 14	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2014
22 Oct 14	ANNOUNCEMENT PURSUANT TO RULE 13.09(2)(a) OF THE LISTING RULES COMPLETION OF THE DISPOSAL AGREEMENT
17 Oct 14	CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
10 Oct 14	POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 10 OCTOBER 2014
19 Sep 14	NOTICE OF EXTRAORDINARY GENERAL MEETING
15 Sep 14	BUSINESS UPDATE
29 Aug 14	MAJOR AND CONNTECTED TRANSACTION - DISPOSAL OF ENTIRE ISSUED SHARE CAPITAL OF XI'AN LIJUN PHARMACEUTICAL CO., LTD.
28 Aug 14	CLARIFICATION ANNOUNCEMENT
28 Aug 14	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2014
15 Aug 14	NOTICE OF BOARD MEETING
06 Aug 14	POSITIVE PROFIT ALERT
24 Jun 14	EXERCISE OF SHARE OPTIONS
11 Jun 14	STATUS OF WAIVER ON THE SPECIFIC PERFORMANCE COVENANT UNDER LOAN AGREEMENT
09 Jun 14	STATUS OF SPECIFIC PERFORMANCE COVENANT UNDER LOAN AGREEMENT
05 Jun 14	ANNOUNCEMENT
05 Jun 14	List of Directors and their Role and Function
05 Jun 14	(1) SALE OF EXISTING SHARES BY A SUBSTANTIAL SHAREHOLDER (2) CHANGE IN SHAREHOLDING (3) RESIGNATION OF DIRECTORS AND CHANGE OF AUTHORIZED REPRESENTATIVE
23 May 14	POLL RESULTS OF THE ANNUAL GENERAL MEETING 2014
24 Apr 14	NOTICE OF ANNUAL GENERAL MEETING
23 Apr 14	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2014
08 Apr 14	CLARIFICATION ANNOUNCEMENT
31 Mar 14	UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS
31 Mar 14	Final Dividend
28 Mar 14	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2013
14 Mar 14	DATE OF BOARD MEETING
12 Mar 14	POSITIVE PROFIT ALERT

01 Nov 13	ANNOUNCEMENT PURSUANT TO RULE 13.09(2)(a) OF THE LISTING RULES TERMINATION OF THE SALES AND PURCHASE AGREEMENTS
22 Oct 13	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2013
30 Aug 13	ANNOUNCEMENT FURTHER EXTENSIONS OF LONG STOP DATES OF SALE AND PURCHASE AGREEMENTS
30 Aug 13	BOARD DIVERSITY POLICY ADOPTED ON 1 SEPTEMBER 2013
28 Aug 13	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2013
13 Aug 13	NOTICE OF BOARD MEETING
07 Aug 13	POSITIVE PROFIT ALERT
02 Aug 13	ANNOUNCEMENT PURSUANT TO RULE 13.09(2)(a) OF THE LISTING RULES
30 Jul 13	ANNOUNCEMENT CHANGE OF INFORMATION OF DIRECTOR
01 Jul 13	ANNOUNCEMENT EXTENSIONS OF LONG STOP DATES OF SALE AND PURCHASE AGREEMENTS
24 May 13	POLL RESULTS OF THE ANNUAL GENERAL MEETING 2013
10 May 13	CHANGE OF CHIEF FINANCIAL OFFICER, COMPANY SECRETARY AND ALTERNATE AUTHORISED REPRESENTATIVE
06 May 13	ANNOUNCEMENT PURSUANT TO RULE 13.09(2)(a) OF THE LISTING RULES
11 Apr 13	NOTICE OF ANNUAL GENERAL MEETING
10 Apr 13	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2013
28 Mar 13	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2012
18 Mar 13	DATE OF BOARD MEETING
25 Feb 13	POSITIVE PROFIT ALERT
03 Jan 13	CLARIFICATION ANNOUNCEMENT

28 Dec 12	ANNOUNCEMENT PURSUANT TO RULE 13.09 OF THE LISTING RULES
18 Dec 12	RENEWAL OF CONTINUING CONNECTED TRANSACTION
18 Dec 12	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
18 Dec 12	RESIGNATION OF EXECUTIVE DIRECTORS AND CHANGE OF AUTHORIZED REPRESENTATIVE
30 Nov 12	CHANGE OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS
19 Nov 12	CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
17 Oct 12	GENERAL DISCLOSURE PURSUANT TO RULE 13.18 OF THE LISTING RULES
16 Oct 12	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2012
16 Oct 12	COMPLETION OF THE BONUS ISSUE AND ADJUSTMENTS TO THE SHARE OPTIONS AS A RESULT OF THE BONUS ISSUE
20 Sep 12	POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 20 SEPTEMBER 2012
30 Aug 12	NOTICE OF EXTRAORDINARY GENERAL MEETING
21 Aug 12	PROPOSED BONUS ISSUE OF SHARES AND CHANGE IN BOARD LOT SIZE
21 Aug 12	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2012
14 Aug 12	PRICE-SENSITIVE ANNOUNCEMENT AND RESUMPTION OF TRADING
14 Aug 12	ANNOUNCEMENT
13 Aug 12	SUSPENSION OF TRADING
09 Aug 12	DATE OF BOARD MEETING
25 May 12	POLL RESULTS OF ANNUAL GENERAL MEETING 2012
03 May 12	GRANT OF OPTIONS
20 Apr 12	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2012
10 Apr 12	List of Directors and their Role and Function
05 Apr 12	RESIGNATION OF EXECUTIVE DIRECTOR
02 Apr 12	NOTICE OF ANNUAL GENERAL MEETING
23 Mar 12	List of Directors and their Role and Function
23 Mar 12	Nomination Committee Terms of Reference
23 Mar 12	Remuneration Committee Terms of Reference
23 Mar 12	Audit Committee Terms of Reference
23 Mar 12	Memorandum and Article of Association
23 Mar 12	FORMATION OF NOMINATION COMMITTEE
23 Mar 12	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2011
13 Mar 12	DATE OF BOARD MEETING
23 Feb 12	PROFIT WARNING

28 Oct 11	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2011
24 Oct 11	DATE OF BOARD MEETING
17 Oct 11	RESIGNATION OF NON-EXECUTIVE DIRECTOR
26 Aug 11	CHANGE OF CHIEF FINANCIAL OFFICER, COMPANY SECRETARY AND ALTERNATE AUTHORISED REPRESENTATIVE
26 Aug 11	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2011
16 Aug 11	DATE OF BOARD MEETING
29 Jul 11	RESIGNATION OF DIRECTOR AND CHANGE OF AUTHORIZED REPRESENTATIVE
27 May 11	POLL RESULTS OF ANNUAL GENERAL MEETING 2011
27 Apr 11	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2011
07 Apr 11	NOTICE OF ANNUAL GENERAL MEETING
25 Mar 11	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2010
15 Mar 11	DATE OF BOARD MEETING

29 Oct 10	DISCLOSEABLE TRANSACTION IN RELATION TO THE PROPOSED FORMATION OF A JOINT VENTURE
29 Oct 10	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2010
26 Oct 10	DATE OF BOARD MEETING
04 Oct 10	VOLUNTARY ANNOUNCEMENT
23 Aug 10	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2010
09 Aug 10	DATE OF BOARD MEETING
21 Jul 10	MEMORANDUM OF UNDERSTANDING IN RESPECT OF FORMATION OF JOINT VENTURE
13 Jul 10	PLACEMENT OF EXISTING SHARES
28 May 10	POLL RESULTS OF ANNUAL GENERAL MEETING 2010
30 Apr 10	ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2010
27 Apr 10	COMPLETION OF THE PLACING AND SALE OF EXISTING SHARES AND SUBSCRIPTION FOR NEW SHARES
23 Apr 10	DATE OF BOARD MEETING
15 Apr 10	PLACING AND SALE OF EXISTING SHARES AND SUBSCRIPTION FOR NEW SHARES AND RESUMPTION OF TRADING
14 Apr 10	SUSPENSION OF TRADING
07 Apr 10	NOTICE OF ANNUAL GENERAL MEETING
30 Mar 10	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2009
16 Mar 10	DATE OF BOARD MEETING
25 Feb 10	PROFIT GROWTH

21 Dec 09	RENEWAL OF CONTINUING CONNECTED TRANSACTIONS
18 Dec 09	Announcement
14 Dec 09	ANNOUNCEMENT CANCELLATION OF RMB16,000,000 HK$ SETTLED ZERO COUPON CONVERTIBLE BONDS DUE 2010
14 Dec 09	GENERAL DISCLOSURE PURSUANT TO RULE 13.18 OF THE LISTING RULES
06 Nov 09	ANNOUNCEMENT AND RESUMPTION OF TRADING
06 Nov 09	SUSPENSION OF TRADING
28 Aug 09	NOTICE TO BONDHOLDERS HK$ SETTLED RMB160,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2010
28 Aug 09	ANNOUNCEMENT - ADJUSTMENT OF CONVERSION PRICE OF HK$ SETTLED ZERO COUPON CONVERTIBLE BONDS DUE 2010
28 Aug 09	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2009
29 Jul 09	CHANGE OF DIRECTORS
27 Jul 09	DATE OF BOARD MEETING
13 Jul 09	PROFIT GROWTH
19 Jun 09	GENERAL DISCLOSURE PURSUANT TO RULE 13.18 OF THE LISTING RULES
08 Jun 09	ANNOUNCEMENT - CANCELLATION OF RMB20,000,000 HK$ SETTLED ZERO COUPON CONVERTIBLE BONDS DUE 2010
05 Jun 09	POLL RESULTS OF ANNUAL GENERAL MEETING
29 Apr 09	NOTICE OF ANNUAL GENERAL MEETING
26 Apr 09	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2008
06 Apr 09	DATE OF BOARD MEETING

09 Dec 08	DISCLOSEABLE TRANSACTION ACQUISITION OF LAND-USE RIGHTS IN THE PRC
26 Sep 08	ANNOUNCEMENT - CANCELLATION OF RMB 30,000,000 HK$ SETTLED ZERO COUPON CONVERTIBLE BONDS DUE 2010
16 Sep 08	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2008
02 Sep 08	DATE OF BOARD MEETING
01 Sep 08	APPOINTMENT OF EXECUTIVE DIRECTOR
09 Jul 08	Announcement - Unusual Volume Movements
20 Jun 08	APPOINTMENT OF CHIEF FINANCIAL OFFICER, QUALIFIED ACCOUNTANT AND COMPANY SECRETARY
30 May 08	RETIREMENT OF DIRECTOR, CHANGE OF AUTHORIZED RESPRESENTATIVE, RESIGNATION OF CHIEF FINANCIAL OFFICER,QUALIFIED ACCOUNTANT AND COMPANY SECRETARY
29 Apr 08	Notice of Annual General Meeting
25 Apr 08	ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2007
11 Apr 08	Date of Board Meeting
26 Feb 08	UNUSUAL PRICE MOVEMENTS

20 Dec 07	CONTINUING CONNECTED TRANSACTIONS
10 Sep 07	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2007
29 Aug 07	Date of Board Meeting
28 Aug 07	SUBDIVISION OF SHARES INCREASE IN AUTHORIZED ORDINARY SHARE CAPITAL REFRESHMENT OF GENERAL MANDATE TO ISSUE SHARES AND RE-ELECTION OF DIRECTORS RESULTS OF EXTRAORDINARY GENERAL MEETING
28 Aug 07	Notice To Bondholders HK$ Settled RMB160,000,000 Zero Coupon Convertible Bonds Due 2010
20 Aug 07	Connected Transaction
16 Aug 07	Notice To Bondholders HK$ Settled RMB160,000,000 Zero Coupon Convertible Bonds Due 2010
09 Aug 07	NOTICE OF EXTRAORDINARY GENERAL MEETING
03 Aug 07	PROPOSALS FOR SUBDIVISION OF SHARES AND CHANGE OF BOARD LOT SIZE INCREASE IN AUTHORIZED ORDINARY SHARE CAPITAL AND REFRESHMENT OF GENERAL MANDATE TO ISSUE AND REPURCHASE SHARES
26 Jul 07	RE-DESIGNATION OF EXECUTIVE DIRECTOR, APPOINTMENT OF EXECUTIVE DIRECTORS AND APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
04 Jul 07	Loan Agreement with Specific Performance Covenant GENERAL DISCLOSURE PURSUANT TO RULE 13.18 OF THE LISTING RULES
26 Jun 07	MAJOR AND CONNECTED TRANSACTION RESULTS OF EXTRAORDINARY GENERAL MEETING
11 Jun 07	Notice of Extraordinary General Meeting
08 Jun 07	Announcement - Placing of Existing Shares
22 May 07	Further Delay in despatch of Circular
21 May 07	Clarification Announcement
17 May 07	Proposed Issue of HK$ Settled RMB 160,000,000 Zero Coupon Convertible Bonds Due 2010 and Resumption of Trading
30 Apr 07	Notice of Annual General Meeting
26 Apr 07	Announcement of Final Results for the Year Ended 31 December 2006
20 Apr 07	Delay in Despatch of Circular
16 Apr 07	Change of Address
30 Mar 07	Major and Connected Transaction - Acquisition of the Entire Issued Share Capital and the Shareholder's Loan of New Orient Investments Limited

21 Nov 06	Memorandum of Understanding in Respect of Proposed Acquisition of 55% Equity Interest in SunStone (Tangshan) Pharmaceutical Co., Ltd.
07 Nov 06	Change of Registered Address in Cayman Islands
25 Sep 06	Appointment of Executive Director
01 Sep 06	Announcement of Interim Results for the Six Months Ended 30 June 2006
23 Jun 06	Discloseable and Connected Transaction; Results of Extraordinary General Meeting and Satisfaction of Conditions
23 Jun 06	Discloseable and Connected Transaction; Results of Extraordinary General Meeting and Satisfaction of Conditions
05 Jun 06	Notice of EGM
16 May 06	Discloseable and Connected Transaction; Resumption of Trading
24 Mar 06	Notice of Annual General Meeting
20 Mar 06	Announcement of Final Results for the Year Ended 31 December 2005
21 Feb 06	Clarification Announcement
10 Jan 06	Stabilising Action and the End of Stabilisation Period

21 Dec 05	Exercise of Over-Allotment Option
09 Dec 05	IPO Allotment Results
02 Dec 05	Listing on the Main Board of The Stock Exchange of Hong Kong Limited by way of Placing and Public Offer